Patti_Real
Well-known member
Word on the street (via Reuters) is that a group representing compounding pharmacies launched a lawsuit against the FDA. Apparently, they're steamed about the FDA taking Lilly's weight loss and diabetes meds off the 'shortage' list. https://www.reuters.com/legal/compo...ys-weight-loss-drug-shortage-list-2024-10-07/
Since there's supposedly no shortage, these compounding pharmacies can't just whip up their own versions to meet demand. The lawsuit alleges that the FDA didn't do their due diligence and just took Lilly's word for it. Mounjaro was on the shortage list since late 2022. Semaglutide's still on the list, though.
Since there's supposedly no shortage, these compounding pharmacies can't just whip up their own versions to meet demand. The lawsuit alleges that the FDA didn't do their due diligence and just took Lilly's word for it. Mounjaro was on the shortage list since late 2022. Semaglutide's still on the list, though.